FrancophonIA/ELRC3.0 huggingface dataset:
English: Because Desloratadine Teva is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Aerius.
Slovenian: Ker je zdravilo Desloratadine Teva generično zdravilo, so bile študije omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Aerius.
English: Desloratadine Teva is a medicine containing the active substance desloratadine.
Slovenian: Desloratadine je zdravilo, ki vsebuje zdravilno učinkovino desloratadin.
English: It works by blocking the receptors on which histamine, a substance in the body that causes allergic symptoms, normally fixes itself.
Slovenian: Deluje kot zaviralec receptorjev, na katere se običajno veže histamin, tj. snov v telesu, ki povzroča alergijske simptome.
English: The active substance in Desloratadine Teva, desloratadine, is an antihistamine.
Slovenian: Zdravilna učinkovina zdravila Desloratadine Teva je desloratadin, ki je antihistaminik.
English: Why has Desloratadine Teva been approved?
Slovenian: Zakaj je bilo zdravilo Desloratadine Teva odobreno?
English: What is Desloratadine Teva?
Slovenian: Kaj je zdravilo Desloratadine Teva?
English: How has Desloratadine Teva been studied?
Slovenian: Kako je bilo zdravilo Desloratadine Teva raziskano?
English: What is Desloratadine Teva used for?
Slovenian: Za kaj se zdravilo Desloratadine Teva uporablja?
English: How is Desloratadine Teva used?
Slovenian: Kako se zdravilo Desloratadine Teva uporablja?
English: How does Desloratadine Teva work?
Slovenian: Kako zdravilo Desloratadine Teva deluje?
English: 1 bottle Zero days equivalent to titre prior to inactivation (log10)
Slovenian: (*) Ekvivalent titru pred inaktivacijo
English: The vaccine was also generally well tolerated and shown to be safe.
Slovenian: Živali so cepivo na splošno dobro prenašale in izkazalo se je kot varno.
English: The vaccine also contains ‘adjuvants' (aluminium hydroxide and saponin) to enhance the immune response.
Slovenian: Cepivo vsebuje tudi „adjuvans“ (aluminijev hidroksid in saponin) za povečanje imunskega odziva.
English: The safety of the vaccine was studied in two main laboratory safety studies and a field safety study carried out in cattle as well as two studies carried out in pregnant cows.
Slovenian: Varnost zdravila je bila raziskana v dveh glavnih laboratorijskih študijah varnosti in v terenski študiji varnosti, ki so bile opravljene pri govedu, ter v dveh študijah, opravljenih pri brejih kravah.
English: The studies showed the vaccine prevents viraemia in cattle and offers protection for one year.
Slovenian: Študije so pokazale, da cepivo preprečuje viremijo pri govedu, in da zaščita traja eno leto.
English: Protection starts two weeks after the last injection and lasts for a year.
Slovenian: Zaščita je učinkovita od drugega tedna po zadnji injekciji in traja eno leto.
English: The first injection is given from two and a half months of age and the second injection is given three weeks later.
Slovenian: Prva injekcija se daje od starosti dveh mesecev in pol, druga pa tri tedne pozneje.
English: In 2012 the CVMP considered that the submitted data were adequate for the authorisation of Zulvac 1 Bovis to convert to normal.
Slovenian: Leta 2012 je CVMP menil, da predloženi podatki zadostujejo, da se dovoljenje za promet z zdravilom Zulvac 1 Bovis spremeni v običajno.
English: Cattle may have a slightly raised body temperature following vaccination.
Slovenian: Po cepljenju se lahko pri govedu pojavi rahlo povišana telesna temperatura.
English: Zulvac 1 Bovis was initially authorised under ‘exceptional circumstances'.
Slovenian: Zdravilo Zulvac 1 Bovis je prvotno pridobilo dovoljenje za promet v „izjemnih okoliščinah“.
English: The vaccine is safe for cattle from two and a half months of age onwards and in pregnant cows.
Slovenian: Cepivo je varno za uporabo pri govedu, starejšemu od dveh mesecev in pol ter pri brejih kravah.
English: When it is given to cattle, the immune system recognises the viruses as ‘foreign' and makes antibodies against them.
Slovenian: Ko govedo prejme cepivo, imunski sistem virus prepozna kot „tujek“ in proti njemu razvije protitelesa.
English: The European Medicines Agency (EMA) reviewed additional information submitted according to an agreed timetable on the quality and safety of the vaccine.
Slovenian: Evropska agencija za zdravila je pregledala vse nove podatke o kakovosti in varnosti cepiva, ki so bili predloženi v dogovorjenem časovnem razporedu.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Zulvac 1 Bovis on 05/08/2011.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Zulvac 1 Bovis, veljavno po vsej Evropski uniji, odobrila dne 5. avgusta 2011.
English: The studies aim was to establish the smallest dose of vaccine that prevented viraemia as well as the duration of protection for Zulvac 1 Bovis.
Slovenian: Cilja študij sta bila določiti najmanjši odmerek, ki preprečuje viremijo, in ugotoviti trajanje zaščite po cepljenju s cepivom Zulvac 1 Bovis.
English: In the future, if the animals are exposed to the bluetongue virus, their immune systems will be able to produce antibodies more quickly.
Slovenian: Ob ponovni izpostavitvi virusu bolezni modrega jezika v prihodnosti bo imunski sistem tako hitreje tvoril protitelesa.
English: Zulvac 1 Bovis is a vaccine that is available as a suspension for injection.
Slovenian: Zdravilo Zulvac 1 Bovis je cepivo, ki je na voljo v obliki suspenzije za injiciranje.
English: Other information about Zulvac 1 Bovis:
Slovenian: Druge informacije o zdravilu Zulvac 1 Bovis:
English: It contains inactivated (killed) bluetongue serotype 1 virus.
Slovenian: Vsebuje inaktiviran (uničen) serotip 1 virusa modrega jezika.
English: The withdrawal period for Zulvac 1 Bovis for meat and milk is zero days.
Slovenian: Karenca za cepivo Zulvac 1 Bovis za meso in mleko je nič dni.
English: Zulvac 1 Bovis is a vaccine.
Slovenian: Zdravilo Zulvac 1 Bovis je cepivo.
English: What benefit has Zulvac 1 Bovis shown during the studies?
Slovenian: Kakšne koristi je zdravilo Zulvac 1 Bovis izkazalo med študijami?
English: Zulvac 1 Bovis contains bluetongue virus of one serotype (serotype 1).
Slovenian: Cepivo Zulvac 1 Bovis vsebuje virus bolezni modrega jezika enega tipa (serotip 1).
English: This means that it was not possible to obtain complete information about Zulvac 1 Bovis at the time of the initial authorisation.
Slovenian: To pomeni, da ob prvotni izdaji dovoljenja za promet ni bilo mogoče pridobiti vseh podatkov o cepivu Zulvac 1
English: Zulvac 1 Bovis is used in cattle to protect them against bluetongue disease, an infection caused by the bluetongue virus which is transmitted by midges .
Slovenian: Zdravilo Zulvac 1 Bovis se uporablja pri govedu za zaščito pred boleznijo modrega jezika, tj. okužbo, ki jo povzroča virus modrega jezika, prenašajo pa jo trzače.
English: What is the risk associated with ZULVAC 1 Bovis?
Slovenian: Kakšna tveganja so povezana z zdravilom Zulvac 1 Bovis?
English: The vaccine is used to prevent viraemia (the presence of the viruses in the blood) in cattle from two and a half months of age.
Slovenian: Cepivo se uporablja za preprečevanje viremije (prisotnosti virusov v krvi) pri govedu, starejšem od dveh mesecev in pol. Cepivo se mladičem injicira v mišico v dveh odmerkih.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Zulvac 1 Bovis exceed the risks in the prevention of viraemia caused by bluetongue virus, serotype 1 in cattle from two and a half months of age.
Slovenian: CVMP je zaključil, da so pri govedu, starejšem od dveh mesecev in pol, koristi cepiva Zulvac 1 Bovis pri preprečevanju viremije, ki jo povzroča serotip 1 virusa bolezni modrega jezika, večje od z njim povezanih tveganj.
English: Why has Zulvac 1 Bovis been approved?
Slovenian: Zakaj je bilo zdravilo Zulvac 1 Bovis odobreno?
English: Zulvac 1 Bovis contains bluetongue viruses that have been inactivated so that they cannot cause the disease.
Slovenian: Cepivo Zulvac 1 Bovis vsebuje inaktiviran virus bolezni modrega jezika, ki ne povzroča bolezni.
English: The effectiveness of the vaccine was studied in three main laboratory studies in calves where animals were challenged with bluetongue virus serotype 1, after receiving Zulvac 1 Bovis vaccine containing different amounts of virus.
Slovenian: Živali so izpostavili serotipu 1 virusa bolezni modrega jezika po tem, ko so bile cepljene s cepivom Zulvac 1 Bovis, ki je vsebovalo različne količine virusa.
English: How has Zulvac 1 Bovis been studied?
Slovenian: Kako je bilo zdravilo Zulvac 1 Bovis raziskano?
English: Inactivated vaccine against Bluetongue virus, serotype 1
Slovenian: Zulvac 1 Bovis inaktivirano cepivo proti virusu bolezni modrega jezika, serotip 1
English: What is Zulvac 1 Bovis?
Slovenian: Kaj je zdravilo Zulvac 1 Bovis?
English: What is ZULVAC 1 Bovis used for?
Slovenian: Za kaj se zdravilo Zulvac 1 Bovis uporablja?
English: How does Zulvac 1 Bovis work?
Slovenian: Kako zdravilo Zulvac 1 Bovis deluje?
English: Date of first authorisation: 19 November 2015
Slovenian: Datum prve odobritve: 19. november 2015
English: < 50 years ≥ 50 years
Slovenian: < 50 let ≥ 50 let
English: Disproportionality analysis did not highlight events that met the criteria for signal of disproportionate reporting.
Slovenian: Analiza nesorazmernosti ni izpostavila dogodkov, ki bi izpolnjevali merila za signal nesorazmernega poročanja.
English: ATC code: J05AR18.
Slovenian: Oznaka ATC: J05AR18.
English: See sections 4.2, 4.4 and 5.1.
Slovenian: Glejte poglavja 4.2, 4.4 in 5.1.
English: 3 These are medicinal products within class where similar interactions could be predicted.
Slovenian: 3 To so zdravila znotraj skupine, kjer je mogoče predvideti podobne interakcije.
English: Since the previous review, 6 new cases were identified (5 valid and 1 invalid).
Slovenian: Od predhodnega pregleda je bilo ugotovljenih 6 novih primerov (5 veljavnih in 1 neveljaven).
English: The amount of this medicine in your blood may decrease during pregnancy which may stop it from working properly.
Slovenian: Količina tega zdravila v vaši krvi se lahko med nosečnostjo zmanjša in prepreči njegovo pravilno delovanje.
English: Data are presented as mean (%CV).
Slovenian: Podatki so predstavljeni kot povprečje (% CV).
English: Adults: one tablet each day with food
Slovenian: Odrasli: ena tableta vsak dan s hrano
English: The long-term effects of substantial increases in progestogen exposure are unknown.
Slovenian: Dolgoročni učinki bistvenega zvišanja izpostavljenosti progestogenu niso znani.
English: Cobicistat levels decrease and may not provide sufficient boosting.
Slovenian: Ravni kobicistata se zmanjšajo in morda ne bodo zagotovile zadostne okrepitve.
English: If you have hepatitis B infection, your doctor will carefully consider the best treatment regimen for you.
Slovenian: Če ste okuženi s hepatitisom B, bo zdravnik skrbno razmislil o najboljšem režimu zdravljenja za vas.
English: In some cases, your doctor may need to adjust your dose or check your blood levels.
Slovenian: V nekaterih primerih bo moral zdravnik prilagoditi vaš odmerek ali opraviti preiskave količin v krvi.
English: • Tell your doctor immediately if you are pregnant, think you may be pregnant or are planning to have a baby.
Slovenian: • Takoj obvestite zdravnika, če ste noseči, menite, da bi lahko bili noseči, ali načrtujete zanositev.
English: b Week 96 window was between Day 630 and 713 (inclusive).
Slovenian: b Okno v 96. tednu je med 630. in 713. dnevom (vključno z njima).
English: Age, gender, and ethnicity
Slovenian: Starost, spol in etnična pripadnost
English: Amlodipine Diltiazem Felodipine Nicardipine Nifedipine Verapamil
Slovenian: amlodipin diltiazem felodipin nikardipin nifedipin verapamil
English: Carbamazepine-10,11-epoxide:
Slovenian: karbamazepin-10,11-epoksid:
English: Patients were stratified by prior treatment regimen.
Slovenian: Bolniki so bili stratificirani glede na predhodni režim zdravljenja.
English: The cases evaluated in this review mostly occurred in patients with history of psychiatric events or other external factors reported that may have contributed to the event.
Slovenian: Primeri, ki so bili ovrednoteni v tem pregledu, so se večinoma zgodili pri bolnikih, ki so poročali o preteklih psihiatričnih dogodkih ali drugih zunanjih dejavnikih, ki so lahko prispevali k dogodku.
English: If Genvoya has been prescribed for your child, please note that all the information in this leaflet is addressed to your child (in this case please read “your child” instead of “you”).
Slovenian: Če je bilo zdravilo Genvoya predpisano vašemu otroku, se vse informacije v tem navodilu za uporabo nanašajo na vašega otroka (v tem primeru berite »vaš otrok« namesto »vi«).
English: The dose of clarithromycin should be reduced by 50%.
Slovenian: Odmerek klaritromicina je treba zmanjšati za 50 %.
English: 25-O-desacetyl-rifabutin
Slovenian: 25-O-desacetil-rifabutin
English: Frequencies are defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10) and uncommon (≥ 1/1,000 to
Slovenian: Pogostnost je definirana kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10) in občasni (≥ 1/1.000 do
English: Take both halves of the tablet one after the other to get the full dose.
Slovenian: Vzemite obe polovici tablete eno za drugo, da prejmete celoten odmerek.
English: angioedema3,4, pruritus, urticaria4
Slovenian: angioedem3,4, pruritus, urtikarija4
English: 7 This study was conducted with additional voxilaprevir 100 mg to achieve voxilaprevir exposures expected in
Slovenian: 7 Ta študija je bila opravljena z dodatnim voksilaprevirjem 100 mg za doseganje izpostavljenosti voksilaprevirju,
English: It should be kept in mind that a twice weekly dose of 150 mg may not provide an optimal exposure to rifabutin thus leading to a risk of rifamycin resistance and a treatment failure.
Slovenian: Vedeti je treba, da morda odmerek 150 mg dvakrat tedensko ne zagotavlja optimalne izpostavljenosti rifabutinu, kar ima lahko za posledico rezistenco na rifamicin in neuspeh zdravljenja.
English: Elvitegravir (antacid suspension after ± 2 hours):
Slovenian: elvitegravir (suspenzija antacida po ± 2 urah):
English: • In children aged from 6 years and with body weight at least 25 kg for whom alternative regimens are unsuitable due to toxicities.
Slovenian: • pri otrocih, starih od 6 let, s telesno maso vsaj 25 kg, pri katerih alternativni režimi niso primerni zaradi toksičnosti.
English: Non-black
Slovenian: Ne-črnci
English: However, a large amount of data on pregnant women (more than 1,000 exposed outcomes) indicate no malformative nor foetal/neonatal toxicity associated with emtricitabine.
Slovenian: Vendar pa velika količina podatkov o nosečnicah (več kot 1.000 izidov izpostavljenih nosečnosti) ne kaže na malformacijsko ali feto/neonatalno toksičnost, povezano z emtricitabinom.
English: Changes in lipid laboratory tests
Slovenian: Spremembe laboratorijskih preiskav lipidov
English: • low red blood cell count (anaemia)
Slovenian: • nizko število rdečih krvnih celic (anemija)
English: There are no adequate and well-controlled studies of Genvoya or its components in pregnant women.
Slovenian: Ni ustreznih, dobro kontroliranih študij z zdravilom Genvoya ali njegovimi učinkovinami pri nosečnicah.
English: Although there were no new safety issues identified, the implications of increased emtricitabine exposure remain uncertain (see sections 4.8 and 5.2).
Slovenian: Čeprav niso prepoznali novih vprašanj glede varnosti, so implikacije večje izpostavljenosti emtricitabinu negotove (glejte poglavji 4.8 in 5.2).
English: When treating HIV infection, it is not always possible to tell whether some of the unwanted effects are caused by Genvoya or by other medicines that you are taking at the same time, or by the HIV disease itself.
Slovenian: Pri zdravljenju okužbe z virusom HIV ni vedno mogoče povedati, ali nekatere od naštetih neželenih učinkov povzroča zdravilo Genvoya ali druga zdravila, ki jih jemljete sočasno, ali sama bolezen HIV.
English: If you feel dizzy when taking Genvoya, do not drive or ride a bicycle and do not use any tools or machines.
Slovenian: Če se vam med zdravljenjem z zdravilom Genvoya pojavlja omotičnost, ne vozite avtomobila, ne kolesarite in ne upravljajte orodij ali strojev.
English: Careful dose titration of the antidepressant and monitoring for antidepressant response is recommended.
Slovenian: Priporoča se skrbno titriranje odmerka antidepresiva in spremljanje odziva na antidepresiv.
English: With other sedatives/hypnotics, dose reduction may be necessary and concentration monitoring is recommended.
Slovenian: Pri drugih sedativih/hipnotikih bo morda treba odmerek zmanjšati, priporoča pa se spremljanje koncentracij.
English: Possible serious side effects: tell a doctor immediately
Slovenian: Možni resni neželeni učinki: takoj obvestite svojega zdravnika
English: The mean age was 48 years (range 23-64).
Slovenian: Povprečna starost je bila 48 let (razpon 23-64).
English: No data are available to make dose recommendations in children aged less than 12 years with renal impairment or in children less than 18 years with end stage renal disease.
Slovenian: Ni podatkov, na podlagi katerih bi podali priporočila o odmerjanju pri otrocih, mlajših od 12 let, z ledvično okvaro ali pri otrocih, mlajših od 18 let s končno ledvično odpovedjo.
English: Selective serotonin reuptake inhibitors (SSRIs) Escitalopram
Slovenian: selective serotonin reuptake inhibitors) escitalopram
English: Table 1: Interactions between the individual components of Genvoya and other medicinal products
Slovenian: Preglednica 1: Interakcije med posameznimi učinkovinami zdravila Genvoya in drugimi zdravili
English: INR should continue to be monitored during the first weeks following ceasing treatment with Genvoya.
Slovenian: INR je treba še naprej spremljati prve tedne po prenehanju zdravljenja z zdravilom Genvoya.
English: Look out for any symptoms of infection or other symptoms such as: muscle weakness weakness beginning in the hands and feet and moving up towards the trunk of the body palpitations, tremor or hyperactivity.
Slovenian: Bodite pozorni na kakršne koli simptome okužbe ali druge simptome, kot so: oslabelost mišic oslabelost, ki se začne v dlaneh in stopalih in se premika proti trupu razbijanje srca (palpitacije), tresavica ali hiperaktivnost
English: The substantial reduction in elvitegravir exposure may result in virological failure and an increased risk of mother-to-child transmission of HIV infection.
Slovenian: Pomembno zmanjšanje izpostavljenosti elvitegravirju lahko povzroči virološki neuspeh in povečano tveganje za prenos okužbe s HIV z matere na otroka.
English: Clinical monitoring is recommended due to the potential for hyperkalaemia.
Slovenian: Priporočeno je klinično spremljanje zaradi možnosti hiperkaliemije.
English: Study GS-US-292-1515
Slovenian: Študija GS-US-292-1515
English: anaemia1
Slovenian: anemija1
English: Treatment of overdose with Genvoya consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient.
Slovenian: Zdravljenje prevelikega odmerka z zdravilom Genvoya načeloma predstavljajo podporni ukrepi, vključno s spremljanjem vitalnih znakov in opazovanjem kliničnega stanja bolnika.
English: As a result, the amounts of Genvoya or other medicines in your blood may be affected.
Slovenian: To lahko posledično vpliva na količino zdravila Genvoya ali drugih zdravil v vaši krvi.
English: Assessment of adverse reactions is based on safety data from across all Phase 2 and 3 studies in which 2,396 patients received Genvoya and from post-marketing experience.
Slovenian: Ocena neželenih učinkov temelji na podatkih o varnosti iz vseh študij faze 2 in 3, v katerih je 2.396 oseb prejemalo zdravilo Genvoya, ter iz izkušenj v obdobju trženja.
English: Stopping Genvoya can seriously affect your response to future treatment.
Slovenian: Prenehanje jemanja zdravila Genvoya lahko resno vpliva na vaš odziv na prihodnje zdravljenje.
English: Children aged 8 to < 12 years, > 25 kg
Slovenian: Otroci, stari 8 do < 12 let, > 25 kg
English: 2T = second trimester; 3T = third trimester; PP =postpartum a paired comparisons b P<0.10 compared with postpartum
Slovenian: 2T = drugi trimester; 3T = tretji trimester; PP = poporodno obdobje a sparjene primerjave b P < 0,10 v primerjavi s poporodnim obdobjem
English: For patients who are unable to swallow the tablet whole, the tablet may be split in half and both halves taken one after the other, ensuring that the full dose is taken.
Slovenian: Za bolnike, ki ne morejo pogoltniti cele tablete, se lahko tableto prepolovi, vendar morajo bolniki vzeti obe polovici eno za drugo, da prejmejo celoten odmerek.
English: • heart medicines, such as:
Slovenian: • zdravila za srce, kot so:
English: • alpha 1-adrenoreceptor antagonists: alfuzosin
Slovenian: • antagonisti adenoreceptorja alfa 1: alfuzosin
English: Do not give this medicine to children aged 5 years or under, or weighing less than 25 kg regardless of age.
Slovenian: Tega zdravila ne dajajte otrokom, starim 5 let ali manj, ali s telesno maso manj kot 25 kg, ne glede na starost.
English: Ex vivo binding of tenofovir alafenamide to human plasma proteins in samples collected during clinical studies was approximately 80%.
Slovenian: Ex vivo vezava tenofoviralafenamid na humane plazemske proteine v vzorcih, odvzetih med kliničnimi študijami, je bila približno 80 %.
English: It is recommended that you do not breast-feed to avoid passing the virus to the baby in breast milk.
Slovenian: Priporočljivo je, da ne dojite, da s tem preprečite prenos virusa preko mleka na dojenčka.
English: You should not take Genvoya with medicines containing:
Slovenian: Zdravila Genvoya ne smete jemati z zdravili, ki vsebujejo:
English: The safety profile in paediatric patients who received treatment with Genvoya was similar to that in adults.
Slovenian: Varnostni profil pri pediatričnih bolnikih, ki so prejemali zdravljenje z zdravilom Genvoya, je bil podoben kot pri odraslih.
English: It is important not to stop taking Genvoya without talking to your doctor: see section 3, Do not stop taking Genvoya.
Slovenian: Pomembno je, da zdravila Genvoya ne prenehate jemati, ne da bi se pogovorili z zdravnikom: glejte poglavje 3, Ne prenehajte jemati zdravila Genvoya.
English: What Genvoya is and what it is used for
Slovenian: Kaj je zdravilo Genvoya in za kaj ga uporabljamo
English: A cumulative review of all cases related to suicide-related events showed a total of 42 valid cases reporting 48 suicide-related events for Genvoya (13 from spontaneous, 29 from clinical trials).
Slovenian: Kumulativni pregled vseh primerov, povezanih z dogodki v povezavi s samomorom, je pokazal skupno 42 veljavnih primerov poročanj o 48 dogodkih v povezavi s samomorom za zdravilo Genvoya (13 je bilo spontanih, 29 iz kliničnih preskušanj).
English: Emtricitabine can be removed by haemodialysis, which removes approximately 30% of the emtricitabine dose over a 3 hour dialysis period starting within 1.5 hours of emtricitabine dosing.
Slovenian: Emtricitabin se lahko odstrani s hemodializo, ki odstrani približno 30 % odmerka emtricitabina v 3 urah dialize, če se začne v 1,5 ure po odmerjanju emtricitabina.
English: Aromatic and aliphatic hydroxylation or glucuronidation metabolites are present in very low levels, displaying considerably lower antiviral activity against HIV-1 and do not contribute to the overall antiviral activity of elvitegravir.
Slovenian: Aromatski in alifatski presnovki hidroksilacije ali presnovki glukuronidacije so prisotni v zelo nizkih ravneh, kar kaže na znatno nižjo protivirusno aktivnost proti HIV-1 in ne prispeva k splošni protivirusni aktivnosti elvitegravirja.
English: Three patients had virologic failure at Week 48; there was no virologic resistance detected to Genvoya.
Slovenian: Trije bolniki so imeli virološki neuspeh v 48. tednu; virološke rezistence na zdravilo Genvoya niso odkrili.
English:  If you notice the side effects described above, tell your doctor immediately.
Slovenian:  Če opazite zgoraj opisane neželene učinke, takoj obvestite svojega zdravnika.